Self-Assembled Nanogel of Pluronic-Conjugated Heparin as a Versatile Drug Nanocarrier

被引:43
作者
Choi, Jong Hoon [1 ]
Joung, Yoon Ki [1 ]
Bae, Jin Woo [1 ]
Choi, Jang Won [1 ,2 ]
Tran Ngoc Quyen [1 ]
Park, Ki Dong [1 ]
机构
[1] Ajou Univ, Dept Mol Sci & Technol, Suwon 443749, South Korea
[2] Amore Pacific Co R&D Ctr, Gyeonggi Do 446729, South Korea
关键词
heparin; nanogel; Pluronic; nanocarrier; monoclonal antibody; micelles; BLOCK-COPOLYMERS; MONOCLONAL-ANTIBODY; SUSTAINED-RELEASE; DELIVERY; DOXORUBICIN; MICELLE; ACTIVATION; SURFACES;
D O I
10.1007/s13233-011-0214-4
中图分类号
O63 [高分子化学(高聚物)];
学科分类号
070305 ; 080501 ; 081704 ;
摘要
Heparin has not been used as a macromolecule to prepare nanocarriers for drug delivery, even though it has advantageous structural features, such as a negatively charged structure and presence of specific binding domains of proteins. In this study, a nanogel of a Pluronic-conjugated heparin was prepared by direct dissolution to develop a versatile drug nanocarrier composed of heparin. The aqueous nanogel solution of the heparin-Pluronic (HP) conjugate, exhibited higher stability than the micelles and smaller hydrodynamic size than 100 nm. The drug encapsulation test demonstrated that the HP nanogel encapsulates efficiently both hydrophobic small molecules and proteins. The release profile of indomethacin (IMC) was almost zero-order without a burst due to the presence of heparin, which appears to be advantageous comparing to polymeric micelles. Circular dichroism (CD) and gel electrophoresis demonstrated that the stability of monoclonal antibodies (3D8 scFv) encapsulated into the HP nanogel had been maintained. Overall, the self-assembled HP nanogel may be a versatile and promising nanocarrier for a range of drugs in drug delivery applications.
引用
收藏
页码:180 / 188
页数:9
相关论文
共 30 条
[1]   Nano-engineering block copolymer aggregates for drug delivery [J].
Allen, C ;
Maysinger, D ;
Eisenberg, A .
COLLOIDS AND SURFACES B-BIOINTERFACES, 1999, 16 (1-4) :3-27
[2]   POLOXAMER ASSOCIATION IN AQUEOUS-SOLUTION [J].
ALSADEN, AA ;
WHATELEY, TL ;
FLORENCE, AT .
JOURNAL OF COLLOID AND INTERFACE SCIENCE, 1982, 90 (02) :303-309
[3]   Pluronic block copolymers: Evolution of drug delivery concept from inert nanocarriers to biological response modifiers [J].
Batrakova, Elena V. ;
Kabanov, Alexander V. .
JOURNAL OF CONTROLLED RELEASE, 2008, 130 (02) :98-106
[4]   Nanoparticle and targeted systems for cancer therapy [J].
Brannon-Peppas, L ;
Blanchette, JO .
ADVANCED DRUG DELIVERY REVIEWS, 2004, 56 (11) :1649-1659
[5]  
Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391
[6]   Fabrication of Endothelial Cell-Specific Polyurethane Surfaces co-Immobilized with GRGDS and YIGSR Peptides [J].
Choi, Won Sup ;
Bae, Jin Woo ;
Joung, Yoon Ki ;
Park, Ki Dong ;
Lee, Mi Hee ;
Park, Jong-Chul ;
Kwon, Il Keun .
MACROMOLECULAR RESEARCH, 2009, 17 (07) :458-463
[7]   Formulation and delivery issues for monoclonal antibody therapeutics [J].
Daugherty, Ann L. ;
Mrsny, Randall J. .
ADVANCED DRUG DELIVERY REVIEWS, 2006, 58 (5-6) :686-706
[8]  
Fatma N, 2000, INVEST OPHTH VIS SCI, V41, pS628
[9]   Heparin-conjugated star-shaped PLA for improved biocompatibility [J].
Go, Dong Hyun ;
Joung, Yoon Ki ;
Park, Sun Young ;
Park, Yong Doo ;
Park, Ki Donp .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2008, 86A (03) :842-848
[10]   Heparin oligosaccharides: Inhibitors of the biological activity of bFGF on Caco-2 cells [J].
Jayson, GC ;
Gallagher, JT .
BRITISH JOURNAL OF CANCER, 1997, 75 (01) :9-16